Prévention cardio-vasculaire Réadaptation
JESFC 2025

Réadaptation cardiaque et prévention secondaire

Publié le jeudi 16 janvier 2025

Modérateur(s) :

Antoine Faure , Laura Krapf

Orateur(s) :

David Stévant , Marine Kirsch , Matthieu Wargny , Ngone Diaba Gaye , Marine Pierre , Gilles Chatellier , Faten El Ayech Boudiche , Pierre-Marie Leprêtre , Sandra Le Guyader-Peyrou , Hervé Libérus Ayéwanou Edorh , Aitor Guitarte Vidaurre

Dans la session

David Stévant Feasability and efficacy of a targeted mailing campaign to improve pneumococcal vaccine coverage : a local pilot study
Matthieu Wargny Underuse of lipid-lowering therapies in patients with established atherosclerotic cardiovascular disease (ASCVD) in 2021: results from the French n...
Ngone Diaba Gaye Patient education in cardiovascular disease in Sub-Saharan Africa: the ?Heart School? pilot project at IPMS/Cheikh Anta Diop University of Dakar, S...
Marine Pierre Association between regional cardiac rehabilitation and heart transplantation rates in France (2014-2022)
Gilles Chatellier Care pathway of a cohort of hospitalized heart failure patients in Paris (Ile de France). Insight from SNDS data base at one year
Faten El Ayech Boudiche Therapeutic targets achievement in secondary prevention 12 months after myocardial infarction in a tunisian university center
Pierre-Marie Leprêtre Drug therapy optimization does not explain response status of exercise based cardiac rehabilitation among heart failure patients with reduced eject...
Hervé Libérus Ayéwanou Edorh Comparison of short term benefits of inpatient and outpatient cardiac rehabilitation in heart failure with reduced ejection fraction
Aitor Guitarte Vidaurre MarfanPower : results of a clinical trial on a home based rehabilitation program for children and young patients with Marfan syndrome

Partager l'article :